NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia

Rationale: There is increasing evidence that functional deficits in schizophrenia may be driven by a reduction in the signal-to-noise ratio (SNR) and consistent timing of neural signals. This study examined the extent to which exposure to the NMDA receptor antagonists ketamine and MK801, frequently...

Full description

Bibliographic Details
Main Authors: John A. Saunders, Michael J. Gandal, Steve J. Siegel
Format: Article
Language:English
Published: Elsevier 2012-04-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996112000046
_version_ 1829492188797468672
author John A. Saunders
Michael J. Gandal
Steve J. Siegel
author_facet John A. Saunders
Michael J. Gandal
Steve J. Siegel
author_sort John A. Saunders
collection DOAJ
description Rationale: There is increasing evidence that functional deficits in schizophrenia may be driven by a reduction in the signal-to-noise ratio (SNR) and consistent timing of neural signals. This study examined the extent to which exposure to the NMDA receptor antagonists ketamine and MK801, frequently used pharmacological models of schizophrenia, recreate deficits in electrophysiological markers of disturbed brain circuits that are thought to underlie the illness. Furthermore, this study characterizes the specificity of these differences across the frequency spectrum so as to help identify the nature of selective circuit abnormalities that mediate each oscillatory response as relevant to schizophrenia. Design: Mouse EEG was recorded during exposure to repeated auditory stimuli after injection of either vehicle or drug. The dose–response relationship for each electrophysiological measure was determined for ketamine and MK-801. Time-frequency analyses were performed to assess baseline, total, and evoked power and intertrial coherence (ITC) at low (5–10 Hz) and high (35–80 Hz)-frequencies. Results: High frequency evoked and total power was decreased by MK-801 and ketamine in a dose-dependent fashion. High frequency baseline power was increased by MK-801 and ketamine in a dose-dependent fashion. Similar to evoked power, high frequency inter-trial coherence was dose-dependently decreased by both drugs. Low frequency ITC was only decreased by ketamine. Conclusions: Both ketamine and MK-801 cause alterations in high-frequency baseline (noise), total (signal), and evoked (signal) power resulting in a loss of high frequency SNR that is thought to primarily reflect local circuit activity. These changes indicate an inappropriate increase in baseline activity, which can also be interpreted as non-task related activity. Ketamine induced a loss of intertrial coherence at low frequencies, indicating a loss of consistency in low-frequency circuit mechanisms. As a proportion of baseline power, both drugs had a relative shift from low to high frequencies, reflecting a change in the balance of brain activity from coordination of global regions to a pattern of discoordinated, autonomous local activity. These changes are consistent with a pattern of fragmented regional brain activity seen in schizophrenia.
first_indexed 2024-12-16T06:10:13Z
format Article
id doaj.art-9a3fc6af838349769fe120af253f0e6e
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-16T06:10:13Z
publishDate 2012-04-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-9a3fc6af838349769fe120af253f0e6e2022-12-21T22:41:25ZengElsevierNeurobiology of Disease1095-953X2012-04-0146193100NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophreniaJohn A. Saunders0Michael J. Gandal1Steve J. Siegel2Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA; Bioengineering Graduate Group, University of Pennsylvania, Philadelphia, PA, 19104, USATranslational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USATranslational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA; Bioengineering Graduate Group, University of Pennsylvania, Philadelphia, PA, 19104, USA; Corresponding author at: Dept. of Psychiatry, University of Pennsylvania, Translational Research Laboratories, 125 S 31st St, Philadelphia, PA 19104, USA. Fax: +1 215 573 2041.Rationale: There is increasing evidence that functional deficits in schizophrenia may be driven by a reduction in the signal-to-noise ratio (SNR) and consistent timing of neural signals. This study examined the extent to which exposure to the NMDA receptor antagonists ketamine and MK801, frequently used pharmacological models of schizophrenia, recreate deficits in electrophysiological markers of disturbed brain circuits that are thought to underlie the illness. Furthermore, this study characterizes the specificity of these differences across the frequency spectrum so as to help identify the nature of selective circuit abnormalities that mediate each oscillatory response as relevant to schizophrenia. Design: Mouse EEG was recorded during exposure to repeated auditory stimuli after injection of either vehicle or drug. The dose–response relationship for each electrophysiological measure was determined for ketamine and MK-801. Time-frequency analyses were performed to assess baseline, total, and evoked power and intertrial coherence (ITC) at low (5–10 Hz) and high (35–80 Hz)-frequencies. Results: High frequency evoked and total power was decreased by MK-801 and ketamine in a dose-dependent fashion. High frequency baseline power was increased by MK-801 and ketamine in a dose-dependent fashion. Similar to evoked power, high frequency inter-trial coherence was dose-dependently decreased by both drugs. Low frequency ITC was only decreased by ketamine. Conclusions: Both ketamine and MK-801 cause alterations in high-frequency baseline (noise), total (signal), and evoked (signal) power resulting in a loss of high frequency SNR that is thought to primarily reflect local circuit activity. These changes indicate an inappropriate increase in baseline activity, which can also be interpreted as non-task related activity. Ketamine induced a loss of intertrial coherence at low frequencies, indicating a loss of consistency in low-frequency circuit mechanisms. As a proportion of baseline power, both drugs had a relative shift from low to high frequencies, reflecting a change in the balance of brain activity from coordination of global regions to a pattern of discoordinated, autonomous local activity. These changes are consistent with a pattern of fragmented regional brain activity seen in schizophrenia.http://www.sciencedirect.com/science/article/pii/S0969996112000046SchizophreniaElectrophysiologyEndophenotypeAnimal modelsNMDA antagonist
spellingShingle John A. Saunders
Michael J. Gandal
Steve J. Siegel
NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia
Neurobiology of Disease
Schizophrenia
Electrophysiology
Endophenotype
Animal models
NMDA antagonist
title NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia
title_full NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia
title_fullStr NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia
title_full_unstemmed NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia
title_short NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia
title_sort nmda antagonists recreate signal to noise ratio and timing perturbations present in schizophrenia
topic Schizophrenia
Electrophysiology
Endophenotype
Animal models
NMDA antagonist
url http://www.sciencedirect.com/science/article/pii/S0969996112000046
work_keys_str_mv AT johnasaunders nmdaantagonistsrecreatesignaltonoiseratioandtimingperturbationspresentinschizophrenia
AT michaeljgandal nmdaantagonistsrecreatesignaltonoiseratioandtimingperturbationspresentinschizophrenia
AT stevejsiegel nmdaantagonistsrecreatesignaltonoiseratioandtimingperturbationspresentinschizophrenia